<VariationArchive VariationID="16576" VariationName="NM_000123.4(ERCC5):c.2751del (p.Lys917fs)" VariationType="Deletion" Accession="VCV000016576" Version="4" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-06-23" DateCreated="2016-08-22" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="31615" VariationID="16576">
      <GeneList>
        <Gene Symbol="BIVM-ERCC5" FullName="BIVM-ERCC5 readthrough" GeneID="100533467" HGNC_ID="HGNC:43690" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>13q33.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="102807146" stop="102875995" display_start="102807146" display_stop="102875995" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="103459495" stop="103528350" display_start="103459495" display_stop="103528350" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="ERCC5" FullName="ERCC excision repair 5, endonuclease" GeneID="2073" HGNC_ID="HGNC:3437" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>13q33.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="102846032" stop="102875995" display_start="102846032" display_stop="102875995" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="103498190" stop="103528350" display_start="103498190" display_stop="103528350" Strand="+" />
          </Location>
          <OMIM>133530</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000123.4(ERCC5):c.2751del (p.Lys917fs)</Name>
      <CanonicalSPDI>NC_000013.11:102872261:AAAAAAAAA:AAAAAAAA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>13q33.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="102872262" stop="102872262" display_start="102872262" display_stop="102872262" variantLength="1" positionVCF="102872261" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="103524612" stop="103524612" display_start="103524612" display_stop="103524612" variantLength="1" positionVCF="103524611" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>K917fs</ProteinChange>
      <ProteinChange>K1371fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.103524620del" Assembly="GRCh37">
            <Expression>NC_000013.10:g.103524620del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.11" sequenceAccession="NC_000013" sequenceVersion="11" change="g.102872270del" Assembly="GRCh38">
            <Expression>NC_000013.11:g.102872270del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007146.1" sequenceAccession="NG_007146" sequenceVersion="1" change="g.31447del">
            <Expression>NG_007146.1:g.31447del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001204425.2" sequenceAccession="NM_001204425" sequenceVersion="2" change="c.4113del">
            <Expression>NM_001204425.2:c.4113del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001191354.2" sequenceAccession="NP_001191354" sequenceVersion="2" change="p.Lys1371fs">
            <Expression>NP_001191354.2:p.Lys1371fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000123.4" sequenceAccession="NM_000123" sequenceVersion="4" change="c.2751del" MANESelect="true">
            <Expression>NM_000123.4:c.2751del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000114.3" sequenceAccession="NP_000114" sequenceVersion="3" change="p.Lys917fs">
            <Expression>NP_000114.3:p.Lys917fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_464" sequenceAccession="LRG_464">
            <Expression>LRG_464:g.31447del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_464t1" sequenceAccession="LRG_464t1">
            <Expression>LRG_464t1:c.2751del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_464p1" sequenceAccession="LRG_464p1" change="p.Lys917fs">
            <Expression>LRG_464p1:p.Lys917fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA257536" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="133530.0011" DB="OMIM" />
        <XRef Type="rs" ID="752661599" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000123.4(ERCC5):c.2751del (p.Lys917fs) AND Xeroderma pigmentosum, group G" Accession="RCV000018044" Version="26">
        <ClassifiedConditionList TraitSetID="5436">
          <ClassifiedCondition DB="MedGen" ID="C0268141">Xeroderma pigmentosum, group G</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000123.4(ERCC5):c.2751del (p.Lys917fs) AND Xeroderma pigmentosum" Accession="RCV001194154" Version="1">
        <ClassifiedConditionList TraitSetID="7951">
          <ClassifiedCondition DB="MedGen" ID="C0043346">Xeroderma pigmentosum</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-10-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000123.4(ERCC5):c.2751del (p.Lys917fs) AND not provided" Accession="RCV003556040" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-19" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2016-08-22" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11841555</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23370536</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24700531</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7951" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="7021" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Xeroderma pigmentosum</ElementValue>
                <XRef ID="Xeroderma+pigmentosum/7564" DB="Genetic Alliance" />
                <XRef ID="MONDO:0019600" DB="MONDO" />
                <XRef ID="44600005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Xeroderma pigmentosa</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">XP</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7910" />
                <XRef ID="7910" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Xeroderma pigmentosum (XP) is characterized by: Acute sun sensitivity (severe sunburn with blistering, persistent erythema on minimal sun exposure) with marked freckle-like pigmentation of the face before age two years; Sunlight-induced ocular involvement (photophobia, severe keratitis, atrophy of the skin of the lids, ocular surface neoplasms); Greatly increased risk of sunlight-induced cutaneous neoplasms (basal cell carcinoma, squamous cell carcinoma, melanoma) within the first decade of life. Approximately 25% of affected individuals have neurologic manifestations (acquired microcephaly, diminished or absent deep tendon stretch reflexes, progressive sensorineural hearing loss, progressive cognitive impairment, and ataxia). The most common causes of death are skin cancer, neurologic degeneration, and internal cancer. The median age at death in persons with XP with neurodegeneration (29 years) was found to be younger than that in persons with XP without neurodegeneration (37 years).</Attribute>
                <XRef ID="NBK1397" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301571</ID>
                <ID Source="BookShelf">NBK1397</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="910" DB="Orphanet" />
              <XRef ID="C0043346" DB="MedGen" />
              <XRef ID="MONDO:0019600" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5436" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6133" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Xeroderma pigmentosum type 7</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Xeroderma pigmentosum, group G</ElementValue>
                <XRef ID="Xeroderma+pigmentosum+type+7/7565" DB="Genetic Alliance" />
                <XRef ID="36454001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">XP, GROUP G</ElementValue>
                <XRef Type="MIM" ID="278780" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Xeroderma pigmentosum VII</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Xeroderma pigmentosum complementation group G</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">XPGC</ElementValue>
                <XRef Type="MIM" ID="278780" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XP7</ElementValue>
                <XRef Type="MIM" ID="278780" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">XPG</ElementValue>
                <XRef Type="MIM" ID="278780" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Xeroderma pigmentosum (XP) is characterized by: Acute sun sensitivity (severe sunburn with blistering, persistent erythema on minimal sun exposure) with marked freckle-like pigmentation of the face before age two years; Sunlight-induced ocular involvement (photophobia, severe keratitis, atrophy of the skin of the lids, ocular surface neoplasms); Greatly increased risk of sunlight-induced cutaneous neoplasms (basal cell carcinoma, squamous cell carcinoma, melanoma) within the first decade of life. Approximately 25% of affected individuals have neurologic manifestations (acquired microcephaly, diminished or absent deep tendon stretch reflexes, progressive sensorineural hearing loss, progressive cognitive impairment, and ataxia). The most common causes of death are skin cancer, neurologic degeneration, and internal cancer. The median age at death in persons with XP with neurodegeneration (29 years) was found to be younger than that in persons with XP without neurodegeneration (37 years).</Attribute>
                <XRef ID="NBK1397" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5629" />
                <XRef ID="5629" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301571</ID>
                <ID Source="BookShelf">NBK1397</ID>
              </Citation>
              <XRef ID="C0268141" DB="MedGen" />
              <XRef ID="MONDO:0010216" DB="MONDO" />
              <XRef Type="MIM" ID="278780" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="38323" SubmissionDate="2016-08-11" DateLastUpdated="2016-08-22" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="133530.0011_XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G" title="ERCC5, 1-BP DEL, 2743A_XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G" />
        <ClinVarAccession Accession="SCV000038323" DateUpdated="2016-08-22" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2002-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with xeroderma pigmentosum complementation group G (XPG; 278780), Lalle et al. (2002) identified compound heterozygosity for 2 small deletions in the ERCC5 gene. One allele had deletion of an adenosine at position 1491 (133530.0010), and the other had a deletion of an adenosine in a stretch of 9 adenosines at positions 2743 to 2751 of the ERCC5 gene. The authors designated this mutation 2751delA. An intron whose splice donor and acceptor sites are noncanonical is located between the deletion and the termination codon resulting from the frameshift; the mutation caused a minor alternative splicing event that removed the first 2 nucleotides of the following exon (2880-2881del). In this patient, the combination of this splicing event and the single-nucleotide deletion at position 2751 was predicted to restore the reading frame and thereby generate an almost full-length XPG protein of 1,185, instead of 1,186, amino acids. Such a protein would contain an internal stretch of 44 unrelated amino acids.</Attribute>
              <Citation>
                <ID Source="PubMed">11841555</ID>
              </Citation>
              <XRef DB="OMIM" ID="278780" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC5" />
          </GeneList>
          <Name>ERCC5, 1-BP DEL, 2743A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 2743A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="133530.0011" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2671806" SubmissionDate="2020-03-06" DateLastUpdated="2020-06-22" DateCreated="2020-06-22">
        <ClinVarSubmissionID localKey="NM_000123.3:c.2751del|MedGen:C0043346" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001363456" DateUpdated="2020-06-22" DateCreated="2020-06-22" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-10-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24700531</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23370536</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11841555</ID>
          </Citation>
          <Comment>Variant summary: ERCC5 c.2751delA (p.Lys917AsnfsX65) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 248226 control chromosomes (gnomAD). c.2751delA has been reported in the literature in a compound heterozygous individual affected with Xeroderma pigmentosum (Lalle_2002). These data indicate that the variant is likely to be associated with disease. In functional studies, the cells transfected with the variant were highly UV sensitive compared to control cells (Lalle_2002).No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000123.3:c.2751del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Xeroderma pigmentosum</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0043346" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6913290</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7981849" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4916208|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004296520" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11841555</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11841555</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11841555</ID>
          </Citation>
          <Comment>Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. For these reasons, this variant has been classified as Pathogenic. Studies have shown that this premature translational stop signal is associated with altered splicing resulting in multiple RNA products (PMID: 11841555). Experimental studies have shown that this premature translational stop signal affects ERCC5 function (PMID: 11841555). ClinVar contains an entry for this variant (Variation ID: 16576). This variant is also known as K917fs962fsX1186. This premature translational stop signal has been observed in individuals with clinical features of xeroderma pigmentosum (PMID: 11841555; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Lys917Asnfs*65) in the ERCC5 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 270 amino acid(s) of the ERCC5 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000013.10:g.103524612del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9830476" SubmissionDate="2024-06-07" DateLastUpdated="2024-06-17" DateCreated="2024-06-17">
        <ClinVarSubmissionID localKey="3039008585" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005061212" DateUpdated="2024-06-17" DateCreated="2024-06-17" Type="SCV" Version="1" SubmitterName="Neuberg Centre For Genomic Medicine, NCGM" OrgID="508108" OrganizationCategory="laboratory" OrgAbbreviation="NCGM" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The frameshift variant c.2751del (p.Lys917AsnfsTer65) in the ERCC5 gene has been reported previously in a heterozygous state in individuals affected with xeroderma pigmentosum (Drury et al., 2014; Lalle et al., 2022). The p.Lys917AsnfsTer65 variant is absent in 1000 Genomes. It has been submitted to ClinVar as Pathogenic. This variant is predicted to cause a loss of normal protein function through protein truncation. Loss of function variants have been previously reported to be disease causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet DateLastEvaluated="2023-03-20" Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000951" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000123.4:c.2751del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="278780" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14513169</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9830476" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000951" MappingRef="HP">
        <MedGen CUI="C0037268" Name="Abnormality of the skin" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7981849" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2671806" TraitType="Disease" MappingType="Name" MappingValue="Xeroderma pigmentosum" MappingRef="Preferred">
        <MedGen CUI="C0043346" Name="Xeroderma pigmentosum" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9830476" TraitType="Disease" MappingType="XRef" MappingValue="278780" MappingRef="OMIM">
        <MedGen CUI="C0268141" Name="Xeroderma pigmentosum, group G" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="38323" TraitType="Disease" MappingType="Name" MappingValue="XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G" MappingRef="Preferred">
        <MedGen CUI="C0268141" Name="Xeroderma pigmentosum, group G" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

